Agentix (AGTX) Accounts Payables (2014 - 2026)
Agentix's (AGTX) quarterly Accounts Payables came in at $715870.0 in Q1 2026, down 26.11% YoY from $968888.0 in Q1 2025, and up 1.22% on a QoQ basis from $707215.0 in Q4 2025.
Agentix (AGTX) Accounts Payables (2014 - 2026) Analysis & Trends
Agentix (AGTX) has 13 years of Accounts Payables data on file, last reported at $715870.0 in Q1 2026.
- Quarterly Accounts Payables fell 26.11% year-over-year to $715870.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $715870.0 (down 26.11% YoY) and the FY2026 annual result came in at $715870.0, down 26.11% from the prior year.
- Accounts Payables climbed to $715870.0 in Q1 2026, from $707215.0 in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $1.4 million in Q3 2023 to a low of $146909.0 in Q1 2022.
- A 5-year average of $840797.8 and a median of $961661.0 in 2024 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2022 — Accounts Payables sank 37.3% — and 2023, when it jumped 751.68%.
- Tracing AGTX's Accounts Payables over 5 years: stood at $625236.0 in 2022, then soared by 76.95% to $1.1 million in 2023, then retreated by 3.55% to $1.1 million in 2024, then slumped by 33.73% to $707215.0 in 2025, then gained by 1.22% to $715870.0 in 2026.
- The last three Accounts Payables figures came in at $715870.0 (Q1 2026), $707215.0 (Q4 2025), and $711639.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Agentix | 801,339.00 | 801,301.00 | - | 713,344.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 713,344.00 |
| Mar 31, 2026 | 715,870.00 |
| Dec 31, 2025 | 707,215.00 |
| Sep 30, 2025 | 711,639.00 |
| Jun 30, 2025 | 700,149.00 |
| Mar 31, 2025 | 968,888.00 |
| Dec 31, 2024 | 1.07 Mn |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 961,661.00 |
| Dec 31, 2023 | 1.11 Mn |
| Sep 30, 2023 | 1.44 Mn |
| Jun 30, 2023 | 1.33 Mn |
| Mar 31, 2023 | 1.06 Mn |
| Dec 31, 2022 | 625,236.00 |
| Sep 30, 2022 | 405,551.00 |
| Jun 30, 2022 | 155,835.00 |
| Feb 28, 2022 | 146,909.00 |
| Nov 30, 2021 | 120,771.00 |
| Aug 31, 2021 | 121,239.00 |